nodes	percent_of_prediction	percent_of_DWPC	metapath
Arbutamine—ADRB2—prostate cancer	0.91	1	CbGaD
Arbutamine—Masoprocol—IGF1R—prostate cancer	0.00228	0.154	CrCbGaD
Arbutamine—Dobutamine—COMT—prostate cancer	0.00102	0.0689	CrCbGaD
Arbutamine—Salmeterol—CYP3A5—prostate cancer	0.000833	0.0563	CrCbGaD
Arbutamine—Masoprocol—CYP19A1—prostate cancer	0.000721	0.0488	CrCbGaD
Arbutamine—Formoterol—CYP2A6—prostate cancer	0.000704	0.0476	CrCbGaD
Arbutamine—Arformoterol—CYP2A6—prostate cancer	0.000704	0.0476	CrCbGaD
Arbutamine—Salmeterol—ADRB2—prostate cancer	0.000658	0.0445	CrCbGaD
Arbutamine—Fenoterol—ADRB2—prostate cancer	0.000634	0.0428	CrCbGaD
Arbutamine—Ritodrine—ADRB2—prostate cancer	0.000634	0.0428	CrCbGaD
Arbutamine—Norepinephrine—SLC22A3—prostate cancer	0.000626	0.0423	CrCbGaD
Arbutamine—Arformoterol—ADRB2—prostate cancer	0.000575	0.0389	CrCbGaD
Arbutamine—Formoterol—ADRB2—prostate cancer	0.000575	0.0389	CrCbGaD
Arbutamine—Dobutamine—ADRB2—prostate cancer	0.000545	0.0369	CrCbGaD
Arbutamine—Arformoterol—CYP2C19—prostate cancer	0.000495	0.0335	CrCbGaD
Arbutamine—Formoterol—CYP2C19—prostate cancer	0.000495	0.0335	CrCbGaD
Arbutamine—Norepinephrine—SLC22A1—prostate cancer	0.000449	0.0304	CrCbGaD
Arbutamine—Labetalol—ADRB2—prostate cancer	0.000421	0.0284	CrCbGaD
Arbutamine—Epinephrine—SLC22A1—prostate cancer	0.000408	0.0275	CrCbGaD
Arbutamine—Mirabegron—CYP3A4—prostate cancer	0.000394	0.0266	CrCbGaD
Arbutamine—Salmeterol—CYP3A4—prostate cancer	0.00036	0.0244	CrCbGaD
Arbutamine—Isoprenaline—ADRB2—prostate cancer	0.000309	0.0209	CrCbGaD
Arbutamine—Norepinephrine—ADRB2—prostate cancer	0.000287	0.0194	CrCbGaD
Arbutamine—Isoprenaline—CYP1A1—prostate cancer	0.000265	0.0179	CrCbGaD
Arbutamine—Epinephrine—ADRB2—prostate cancer	0.00026	0.0176	CrCbGaD
Arbutamine—Epinephrine—CYP3A4—prostate cancer	0.000142	0.00962	CrCbGaD
Arbutamine—ADRB2—GPCR ligand binding—CXCL8—prostate cancer	3.45e-05	0.000457	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GNG5—prostate cancer	3.44e-05	0.000457	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IGF1R—prostate cancer	3.37e-05	0.000447	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GNG5—prostate cancer	3.37e-05	0.000447	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—CXCL8—prostate cancer	3.35e-05	0.000445	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—JAK2—prostate cancer	3.34e-05	0.000443	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—LPL—prostate cancer	3.23e-05	0.000429	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—IL2—prostate cancer	3.21e-05	0.000425	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PDGFRB—prostate cancer	3.2e-05	0.000425	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—PIK3CB—prostate cancer	3.17e-05	0.000421	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ITGB3—prostate cancer	3.12e-05	0.000414	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—CXCL8—prostate cancer	3.05e-05	0.000404	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ERBB3—prostate cancer	3.03e-05	0.000402	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—FGFR2—prostate cancer	3.02e-05	0.000401	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PTHLH—prostate cancer	3e-05	0.000398	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TGFBR1—prostate cancer	3e-05	0.000398	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKR1C3—prostate cancer	2.95e-05	0.000391	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRKACB—prostate cancer	2.93e-05	0.000389	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PTHLH—prostate cancer	2.93e-05	0.000389	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TGFBR1—prostate cancer	2.93e-05	0.000389	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—IL2—prostate cancer	2.91e-05	0.000386	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TERT—prostate cancer	2.9e-05	0.000385	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKR1C3—prostate cancer	2.88e-05	0.000383	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRKACB—prostate cancer	2.87e-05	0.000381	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PPP3CA—prostate cancer	2.86e-05	0.000379	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—THBS1—prostate cancer	2.86e-05	0.000379	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ANXA1—prostate cancer	2.82e-05	0.000374	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—THBS1—prostate cancer	2.8e-05	0.000371	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PPP3CA—prostate cancer	2.8e-05	0.000371	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—HIF1A—prostate cancer	2.77e-05	0.000368	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRKCZ—prostate cancer	2.77e-05	0.000367	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ANXA1—prostate cancer	2.76e-05	0.000366	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—LEP—prostate cancer	2.71e-05	0.000359	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRKCZ—prostate cancer	2.71e-05	0.000359	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PIK3CG—prostate cancer	2.7e-05	0.000359	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CAV1—prostate cancer	2.68e-05	0.000356	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PARP1—prostate cancer	2.67e-05	0.000354	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGFR4—prostate cancer	2.67e-05	0.000354	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—KDR—prostate cancer	2.65e-05	0.000352	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	2.64e-05	0.000351	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CALCA—prostate cancer	2.64e-05	0.00035	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGFR4—prostate cancer	2.61e-05	0.000347	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PARP1—prostate cancer	2.61e-05	0.000347	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ESR1—prostate cancer	2.58e-05	0.000343	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CALCA—prostate cancer	2.58e-05	0.000343	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CXCL12—prostate cancer	2.58e-05	0.000342	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—BAD—prostate cancer	2.52e-05	0.000335	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CXCL12—prostate cancer	2.52e-05	0.000335	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3CG—prostate cancer	2.45e-05	0.000326	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3CG—prostate cancer	2.44e-05	0.000324	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—APC—prostate cancer	2.44e-05	0.000324	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CASP9—prostate cancer	2.43e-05	0.000322	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IRS1—prostate cancer	2.42e-05	0.000321	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—EGF—prostate cancer	2.42e-05	0.000321	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	2.4e-05	0.000319	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PIK3CD—prostate cancer	2.38e-05	0.000315	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CASP9—prostate cancer	2.37e-05	0.000315	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRKCQ—prostate cancer	2.35e-05	0.000312	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NGFR—prostate cancer	2.35e-05	0.000312	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—GSK3B—prostate cancer	2.34e-05	0.000311	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	2.32e-05	0.000309	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MAP3K7—prostate cancer	2.32e-05	0.000308	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—INS—prostate cancer	2.31e-05	0.000307	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NGFR—prostate cancer	2.3e-05	0.000305	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	2.3e-05	0.000305	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	2.27e-05	0.000302	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CREBBP—prostate cancer	2.27e-05	0.000301	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IGF1—prostate cancer	2.24e-05	0.000297	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGF10—prostate cancer	2.23e-05	0.000297	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—EGFR—prostate cancer	2.23e-05	0.000295	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADRB2—prostate cancer	2.21e-05	0.000293	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGF10—prostate cancer	2.19e-05	0.00029	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—JAK2—prostate cancer	2.18e-05	0.000289	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—MAP2K1—prostate cancer	2.17e-05	0.000288	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MAP2K1—prostate cancer	2.16e-05	0.000287	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3CD—prostate cancer	2.16e-05	0.000286	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—VAV3—prostate cancer	2.16e-05	0.000286	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3CD—prostate cancer	2.15e-05	0.000285	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	2.13e-05	0.000283	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—PIK3CA—prostate cancer	2.13e-05	0.000282	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TGFBR2—prostate cancer	2.13e-05	0.000282	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	2.13e-05	0.000282	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—SERPINE1—prostate cancer	2.12e-05	0.000282	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	2.11e-05	0.00028	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—VAV3—prostate cancer	2.11e-05	0.00028	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—KRAS—prostate cancer	2.1e-05	0.000279	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ITPR1—prostate cancer	2.09e-05	0.000278	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	2.08e-05	0.000276	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PIK3CB—prostate cancer	2.07e-05	0.000275	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—FGF2—prostate cancer	2.06e-05	0.000273	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ITPR1—prostate cancer	2.05e-05	0.000271	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NOS3—prostate cancer	2.03e-05	0.000269	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	2.03e-05	0.000269	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IGF1R—prostate cancer	2e-05	0.000265	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—CXCL8—prostate cancer	1.99e-05	0.000264	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—JAK2—prostate cancer	1.98e-05	0.000263	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—JAK2—prostate cancer	1.97e-05	0.000262	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IGF1R—prostate cancer	1.96e-05	0.00026	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	1.95e-05	0.000258	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—JAK2—prostate cancer	1.94e-05	0.000257	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—PIK3CA—prostate cancer	1.93e-05	0.000256	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MDM2—prostate cancer	1.92e-05	0.000255	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—LPL—prostate cancer	1.92e-05	0.000254	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—IL2—prostate cancer	1.9e-05	0.000252	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PDGFRB—prostate cancer	1.9e-05	0.000252	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ERBB2—prostate cancer	1.9e-05	0.000252	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3CB—prostate cancer	1.88e-05	0.00025	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—LPL—prostate cancer	1.88e-05	0.000249	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3CB—prostate cancer	1.87e-05	0.000248	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—IL2—prostate cancer	1.86e-05	0.000247	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	1.86e-05	0.000247	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ITGB3—prostate cancer	1.85e-05	0.000246	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	1.84e-05	0.000244	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ITGB3—prostate cancer	1.81e-05	0.00024	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	1.81e-05	0.00024	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CXCL8—prostate cancer	1.8e-05	0.000239	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ERBB3—prostate cancer	1.8e-05	0.000238	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGFR2—prostate cancer	1.79e-05	0.000238	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	1.77e-05	0.000235	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CDKN1B—prostate cancer	1.76e-05	0.000233	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ERBB3—prostate cancer	1.76e-05	0.000233	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGFR2—prostate cancer	1.75e-05	0.000233	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—AKT1—prostate cancer	1.74e-05	0.000231	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—IL2—prostate cancer	1.73e-05	0.000229	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CASP3—prostate cancer	1.72e-05	0.000229	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TERT—prostate cancer	1.72e-05	0.000228	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IL2—prostate cancer	1.72e-05	0.000228	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—IL6—prostate cancer	1.71e-05	0.000227	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—IL2—prostate cancer	1.69e-05	0.000224	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TERT—prostate cancer	1.68e-05	0.000223	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CCND1—prostate cancer	1.68e-05	0.000222	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CTNNB1—prostate cancer	1.66e-05	0.00022	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HIF1A—prostate cancer	1.65e-05	0.000218	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MMP9—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CDKN1A—prostate cancer	1.62e-05	0.000215	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PTEN—prostate cancer	1.62e-05	0.000215	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HIF1A—prostate cancer	1.61e-05	0.000214	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—LEP—prostate cancer	1.61e-05	0.000213	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CAV1—prostate cancer	1.59e-05	0.000211	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—AKT1—prostate cancer	1.58e-05	0.000209	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—KDR—prostate cancer	1.57e-05	0.000209	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—LEP—prostate cancer	1.57e-05	0.000209	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CAV1—prostate cancer	1.56e-05	0.000207	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—EP300—prostate cancer	1.54e-05	0.000205	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—KDR—prostate cancer	1.54e-05	0.000204	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ESR1—prostate cancer	1.53e-05	0.000204	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ESR1—prostate cancer	1.5e-05	0.000199	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—SRC—prostate cancer	1.5e-05	0.000199	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—BAD—prostate cancer	1.5e-05	0.000199	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—BAD—prostate cancer	1.46e-05	0.000194	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—VEGFA—prostate cancer	1.46e-05	0.000194	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	1.45e-05	0.000192	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—APC—prostate cancer	1.45e-05	0.000192	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—STAT3—prostate cancer	1.45e-05	0.000192	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IRS1—prostate cancer	1.43e-05	0.00019	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—EGF—prostate cancer	1.43e-05	0.00019	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—APC—prostate cancer	1.42e-05	0.000188	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	1.42e-05	0.000188	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—EGF—prostate cancer	1.4e-05	0.000186	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IRS1—prostate cancer	1.4e-05	0.000186	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GSK3B—prostate cancer	1.39e-05	0.000185	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—INS—prostate cancer	1.37e-05	0.000182	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GSK3B—prostate cancer	1.36e-05	0.000181	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CREBBP—prostate cancer	1.34e-05	0.000178	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MYC—prostate cancer	1.34e-05	0.000178	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—INS—prostate cancer	1.34e-05	0.000178	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TGFB1—prostate cancer	1.34e-05	0.000178	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IGF1—prostate cancer	1.33e-05	0.000176	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—EGFR—prostate cancer	1.32e-05	0.000175	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CREBBP—prostate cancer	1.32e-05	0.000175	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—EGFR—prostate cancer	1.31e-05	0.000175	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IGF1—prostate cancer	1.3e-05	0.000172	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—EGFR—prostate cancer	1.29e-05	0.000172	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	1.28e-05	0.00017	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	1.27e-05	0.000169	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	1.26e-05	0.000168	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	1.26e-05	0.000167	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	1.26e-05	0.000167	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—KRAS—prostate cancer	1.25e-05	0.000166	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	1.25e-05	0.000166	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—KRAS—prostate cancer	1.24e-05	0.000165	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	1.24e-05	0.000164	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	1.23e-05	0.000164	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—KRAS—prostate cancer	1.22e-05	0.000162	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGF2—prostate cancer	1.22e-05	0.000162	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NOS3—prostate cancer	1.2e-05	0.00016	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGF2—prostate cancer	1.19e-05	0.000158	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NOS3—prostate cancer	1.18e-05	0.000156	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—JAK2—prostate cancer	1.17e-05	0.000155	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	1.15e-05	0.000152	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—JAK2—prostate cancer	1.14e-05	0.000152	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MDM2—prostate cancer	1.14e-05	0.000152	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3CA—prostate cancer	1.14e-05	0.000151	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ERBB2—prostate cancer	1.13e-05	0.000149	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	1.12e-05	0.000149	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MDM2—prostate cancer	1.12e-05	0.000148	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	1.11e-05	0.000147	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TP53—prostate cancer	1.1e-05	0.000147	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ERBB2—prostate cancer	1.1e-05	0.000146	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	1.09e-05	0.000144	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CXCL8—prostate cancer	1.07e-05	0.000142	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CXCL8—prostate cancer	1.04e-05	0.000139	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	1.04e-05	0.000138	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	1.03e-05	0.000137	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CASP3—prostate cancer	1.02e-05	0.000136	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IL2—prostate cancer	1.02e-05	0.000135	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	1.02e-05	0.000135	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—IL6—prostate cancer	1.02e-05	0.000135	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IL6—prostate cancer	1.01e-05	0.000134	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	1.01e-05	0.000134	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CASP3—prostate cancer	1e-05	0.000133	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IL2—prostate cancer	9.98e-06	0.000132	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CCND1—prostate cancer	9.95e-06	0.000132	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—IL6—prostate cancer	9.93e-06	0.000132	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	9.85e-06	0.000131	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CCND1—prostate cancer	9.73e-06	0.000129	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MMP9—prostate cancer	9.66e-06	0.000128	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	9.64e-06	0.000128	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	9.62e-06	0.000128	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PTEN—prostate cancer	9.6e-06	0.000127	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MMP9—prostate cancer	9.45e-06	0.000125	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	9.41e-06	0.000125	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PTEN—prostate cancer	9.39e-06	0.000125	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—AKT1—prostate cancer	9.37e-06	0.000124	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—AKT1—prostate cancer	9.32e-06	0.000124	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—AKT1—prostate cancer	9.16e-06	0.000122	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—EP300—prostate cancer	9.16e-06	0.000122	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—EP300—prostate cancer	8.96e-06	0.000119	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SRC—prostate cancer	8.9e-06	0.000118	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SRC—prostate cancer	8.71e-06	0.000116	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—VEGFA—prostate cancer	8.67e-06	0.000115	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—STAT3—prostate cancer	8.59e-06	0.000114	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—VEGFA—prostate cancer	8.48e-06	0.000113	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—STAT3—prostate cancer	8.4e-06	0.000111	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MYC—prostate cancer	7.98e-06	0.000106	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TGFB1—prostate cancer	7.96e-06	0.000106	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MYC—prostate cancer	7.81e-06	0.000104	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—EGFR—prostate cancer	7.8e-06	0.000104	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TGFB1—prostate cancer	7.79e-06	0.000103	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—EGFR—prostate cancer	7.63e-06	0.000101	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—KRAS—prostate cancer	7.37e-06	9.79e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—KRAS—prostate cancer	7.21e-06	9.57e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	6.77e-06	8.99e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	6.63e-06	8.79e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TP53—prostate cancer	6.55e-06	8.7e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TP53—prostate cancer	6.41e-06	8.51e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IL6—prostate cancer	6e-06	7.96e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IL6—prostate cancer	5.87e-06	7.79e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKT1—prostate cancer	5.53e-06	7.34e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKT1—prostate cancer	5.41e-06	7.18e-05	CbGpPWpGaD
